Advaxis and GlaxoSmithKline Biologicals SA Execute License Agreement for Listeriolysin O Protein Technology
September 17, 2003 13:28 ET
|
Advaxis Inc.
PRINCETON, N.J., Sept. 17, 2003 (PRIMEZONE) -- Advaxis, Inc., a developer of cancer vaccines, today announced an agreement with GlaxoSmithKline Biologicals SA ("GSK") relating to certain rights in...